AI-MEL: Image Analysis and Machine Learning for Early Diagnosis and Risk Prediction in Children, Adolescents and Young Adults

Status: Recruiting
Location: See all (3) locations...
Study Type: Observational
SUMMARY

The goal of this study is to develop supportive diagnostic artificial intelligence algorithms to distinguish melanoma from nevi or other benign pigmented skin lesions, especially in younger patients (below the age of 30). The main goals it aims to achieve are: * development of an algorithm based on dermatoscopic images, targeting skin cancer screening in vulnerable populations * development of another algorithm based on histological images, intended to be used by pathologists on lesions that are still suspicious of melanoma after dermatologic assessment * implementation of explainability methods to enable the user to better comprehend the systems' decisions, avoid biases and increase trust in these applications There is no additional time commitment for the study participants for this study, as the data used in this project will be collected in routine clinical practice anyway.

Eligibility
Participation Requirements
Sex: All
Healthy Volunteers: t
View:

• \-

Locations
Other Locations
Germany
University of Tübingen
COMPLETED
Tübingen
Italy
University of Florence
COMPLETED
Florence
Spain
Hospital Clínic de Barcelona
RECRUITING
Barcelona
Contact Information
Primary
Titus J Brinker, PD Dr. med
titus.brinker@nct-heidelberg.de
+49 15175084347
Time Frame
Start Date: 2022-12-01
Estimated Completion Date: 2026-11-30
Participants
Target number of participants: 3000
Related Therapeutic Areas
Sponsors
Collaborators: Hospital Clinic of Barcelona, Fundacio Clinic Barcelona, University of Florence, Universität Tübingen
Leads: German Cancer Research Center

This content was sourced from clinicaltrials.gov